Clinical Trials Browser

INDUSTRY × Endometrial Cancer Recurrent × TIC10 compound × Clear all

NCT03485729 2024-12-24

ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer

Phase 2 Terminated

27 enrolled 11 charts

Endometrial Cancer Recurrent